highly significantP = .0018
A study of the benefit of HSCT showed that the difference in mean overall survival time between those who underwent transplantation (9 allogeneic [allo], 1 autologous) and those who did not was highly significant (31.3 vs 12.8 months; P = .0018). 4 Less information is available on the optimal therapeutic approach to LS-BPDCN specifically.